Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00620685 · ClinicalTrials.gov registry record · Phase 2

A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate

A Phase 2 study of Arthritis, Rheumatoid, sponsored by Pfizer.

Completed
Registry status
Phase 2
Development phase
27
Enrollment target
7
Study locations

NCT00620685 is a Phase 2 study of Arthritis, Rheumatoid that has completed, run by Pfizer. The registered enrollment target is 27 participants, below the 640-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (96% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00620685, a Phase 2 study of Arthritis, Rheumatoid, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 2
Development phase
27 participants
Enrollment target
7
Study locations

Study Summary

The hypothesis of this study is that the p38 inhibitor (PH-797804) will be safe and well tolerated in subjects with rheumatoid arthritis who are taking methotrexate and will not effect the blood levels of methotrexate.

Conditions Studied

Arthritis, Rheumatoid

Interventions

  • DRUG Placebo
  • DRUG PH-797804

Study Locations (7)

Michigan

  • Pfizer Investigational Site - Bingham Farms
  • Pfizer Investigational Site - Kalamazoo

Arizona

  • Pfizer Investigational Site - Phoenix

Colorado

  • Pfizer Investigational Site - Colorado Springs

Florida

  • Pfizer Investigational Site - Miami

Maryland

  • Pfizer Investigational Site - Frederick

Pennsylvania

  • Pfizer Investigational Site - Duncansville

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2008-03
Est. Completion 2008-10
Phase Phase 2

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00620685

The ClinicalTrials.gov registry entry for NCT00620685 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 640-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (96% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00620685 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Michigan, Arizona, Colorado.

Frequently Asked Questions

What is clinical trial NCT00620685 about?

NCT00620685 is a clinical study titled "A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate". The hypothesis of this study is that the p38 inhibitor (PH-797804) will be safe and well tolerated in subjects with rheumatoid arthritis who are taking methotrexate and will not effect the blood levels of methotrexate.

What is the current status of trial NCT00620685?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2008-03. Estimated completion is 2008-10.

What conditions does trial NCT00620685 study?

This clinical trial studies the following conditions: Arthritis, Rheumatoid.

What interventions are being tested in trial NCT00620685?

The interventions under investigation include: Placebo (DRUG), PH-797804 (DRUG).

Who is sponsoring clinical trial NCT00620685?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00620685 being conducted?

This trial has 7 study locations across Arizona, Colorado, Florida, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arthritis, Rheumatoid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arthritis, Rheumatoid

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.